Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Steven John GlaxoSmithKline Coote is active.

Publication


Featured researches published by Steven John GlaxoSmithKline Coote.


Archive | 2001

6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent

Keith Biggadike; Steven John GlaxoSmithKline Coote; Rosalyn Kay Nice


Archive | 2001

Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid

Frederick David Albinson; Steven John GlaxoSmithKline Coote; John Malcolm Robinson


Archive | 2003

Crystalline complexes of fluticasone 2-furoate

Keith Biggadike; Steven John GlaxoSmithKline Coote; Andrew GlaxoSmithKline Craig; David Malcolm Crowe; Victor Witold GlaxoSmithKline Jacewicz; Michael Millan; Rosalyn Kay GlaxoSmithKline Nice; Brian GlaxoSmithKline Noga; John Frederick Seager; Andrew Lewis Theophilus


Archive | 2003

Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form

Keith Biggadike; Steven John GlaxoSmithKline Coote; Brian GlaxoSmithKline Noga; Oort Michiel Mary GlaxoSmithKline Van


Archive | 2003

Process for the production of fluticasone propionate, in particular of polymorphic form 1

Steven John GlaxoSmithKline Coote; Rosalyn Kay Nice; Mark David Wipperman


Archive | 2003

Process for the production of 6.alpha.,9.alpha-difluoro-17.alpha.-(1-oxo-propoxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.beta.-carbothioic acid

Steven John GlaxoSmithKline Coote; Rosalyn Kay GlaxoSmithKline Nice; Mark David Wipperman


Archive | 2003

Anti-inflammatory or anti-allergic androstane complexes

Keith Biggadike; Steven John GlaxoSmithKline Coote; Andrew Simon Craig; Victor Witold GlaxoSmithKline Jacewicz; Michael Millan; John Frederick Seager; Andrew Lewis Theophilus


Archive | 2004

Oxidation process for preparing the intermediate 6α,9α-defluoro-11β,17α-dihydroxy-16α-methyl-androst-1,4-dien-3-one 17β-carboxylic acid

Frederick David Albinson; Steven John GlaxoSmithKline Coote; John Malcolm Robinson


Archive | 2003

NOVEL CRYSTALLINE COMPLEXES

Keith Biggadike; Steven John GlaxoSmithKline Coote; Andrew Simon Craig; Victor Witold GlaxoSmithKline Jacewicz; Michael Millan; John Frederick Seager; Andrew Lewis Theophilus


Archive | 2003

Kristalline komplexe von fluticasone 2-furoat

Keith Biggadike; Steven John GlaxoSmithKline Coote; Andrew GlaxoSmithKline Craig; David Malcolm Crowe; Victor Witold GlaxoSmithKline Jacewicz; Michael Millan; Rosalyn Kay GlaxoSmithKline Nice; Brian GlaxoSmithKline Noga; John Frederick Seager; Andrew Lewis Theophilus

Collaboration


Dive into the Steven John GlaxoSmithKline Coote's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael Millan

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge